Emerging studies highlights the promise of physiological peptides and hybrid agonists to transform therapeutic approaches for systemic diseases. These advanced compounds offer the unique feature to simultaneously engage multiple targets, circumventing the challenges of traditional isolated treatments. By fine-tuning metabolic signaling, they can… Read More